On Tuesday, Henry Schein Inc (NASDAQ:HSIC) reported a second-quarter adjusted EPS of $1.23, down 6.1% year-over-year, beating the consensus of $1.22. Sales were $3.10 billion, an increase of 1%, missing the consensus of $3.27 billion. Sales growth reflects 4.0% growth from acquisitions, a 0.5% decrease resulting from foreign exchange rates, a 0.5% sales decrease from lower sales of personal protective equipment (PPE), primarily the result of lower glove pricing, and the pace of recovery from the cyber incident late last year. Internal sales decreased by 2.4%, including a 0.5% decrease from lower PPE sales. Global dental segment sales were $1.9 billion, down 1.7%, and medical segment sales increased by 5% to $1 billion. Technology ...